{
  "actions": [
    {
      "acted_at": "1976-06-10", 
      "committee": "House Committee on Interstate and Foreign Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to House Committee on Interstate and Foreign Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr14320-94", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Interstate and Foreign Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "94", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1976-06-10", 
  "number": "14320", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to require reporting with respect to adverse drug reactions.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "24", 
    "name": "Simon, Paul", 
    "state": "IL", 
    "thomas_id": "01059", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1976-06-10", 
  "subjects": [
    "Consumer protection", 
    "Drug adulteration", 
    "Drug law and legislation", 
    "Drugs", 
    "Government records, documents, and information"
  ], 
  "subjects_top_term": "Drug law and legislation", 
  "summary": {
    "as": "Introduced", 
    "date": "1976-06-10", 
    "text": "Amends the Federal Food, Drug, and Cosmetic Act to require that any person who administers a drug to an individual who subsequently suffers an adverse reaction to such drug, and who has reason to believe such drug is adulterated, shall report such facts to the Secretary of Health, Education, and Welfare and shall retain all quantities of the drug in the control of such person."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to require reporting with respect to adverse drug reactions.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T18:33:30-05:00"
}